Parkinson's disease related Dementia Market to Grow at a Healthy Growth Rate During the Forecast Period (2019-32) - Asserts DelveInsight

(Albany, US) DelveInsight's "Parkinson's disease related Dementia Market Insights, Epidemiology, and Market Forecast-2032" report provides an in-depth understanding of the disease, historical and forecasted epidemiology, as well as Parkinson's disease related Dementia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key facts of the Parkinson's disease related Dementia Market
1. Parkinson's disease is a fairly common neurological disorder in older adults, estimated to affect nearly 2% of those over age 65.
2. As per the estimate by the National Parkinson's Foundation one million Americans are affected by Parkinson's disease in 2020.
3. Recent studies following people with Parkinson's over the entire course of their illness estimate that 50 to 80% of those with the disease may experience dementia.
4. Some studies have reported that the average time from onset of Parkinson's to developing dementia is about 10 years.

To know more facts about Parkinson's disease related Dementia Market report, Click here: https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key benefits of the Parkinson's disease related Dementia Market report:
1. The study provides a detailed review of Parkinson's disease related Dementia, including its causes, signs and symptoms, pathophysiology, diagnosis, and current treatments.
2. Study of the 7MM has offered comprehensive insight into the epidemiology and management of Parkinson's disease related Dementia.
3. Furthermore, an all-inclusive description of both present and emerging Parkinson's disease related Dementia treatments is offered, as well as an analysis of future therapies that will have an influence on the current treatment landscape.
4. The research includes a full evaluation of the Parkinson's disease related Dementia market, both historical and anticipated, as well as drug outreach in the 7MM population.
5. By understanding the trends defining and driving the worldwide Parkinson's disease related Dementia market, the study gives you an advantage when formulating business plans.

To know about the offerings of Parkinson's disease related Dementia Market report, Click here: https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Parkinson's disease related Dementia Overview

Parkinson's disease related dementia is a decline in thinking and reasoning that develops in many people living with Parkinson's at least a year after diagnosis. The brain changes caused by Parkinson's disease begin in a region that plays a key role in movement, leading to early symptoms that include tremors and shakiness, muscle stiffness, a shuffling step, stooped posture, difficulty initiating movement and lack of facial expression. As brain changes caused by Parkinson's gradually spread, they often begin to affect mental functions, including memory and the ability to pay attention, making sound judgments and planning the steps needed to complete a task.

Common symptoms related to Parkinson's disease related Dementia include:
• Changes in memory, concentration and judgment
• Trouble interpreting visual information
• Muffled speech
• Visual hallucinations
• Delusions, especially paranoid ideas
• Depression, irritability and anxiety
• Sleep disturbances, including excessive daytime drowsiness and rapid eye movement (REM) sleep disorder.

There are currently no treatments available to slow or stop the brain cell damage caused by Parkinson's disease related dementia. However certain medications and therapies such as Cholinesterase inhibitors, Carbidopa-levodopa, Deep brain stimulation, Selective serotonin reuptake inhibitors (SSRIs) and Clonazepam and melatonin may help in improving the symptoms

To know more about Parkinson's disease related Dementia, Click here: https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Parkinson's disease related Dementia Market

The report's Parkinson's disease related Dementia market outlook assists in developing a detailed understanding of historic, current, and forecasted Parkinson's disease related Dementia market trends by analyzing the impact of current Parkinson's disease related Dementia therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This section examines the Parkinson's disease related Dementia market trend of each marketed drug and late stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing market need, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, market impact, and key opinion leaders' perspectives. Parkinson's disease related Dementia market statistics are supplied with pertinent tables and graphs to provide a comprehensive picture of the market at a glance. According to DelveInsight, the Parkinson's disease related Dementia market in 7MM is expected to undergo significant change between 2019 and 2032.

Learn more by requesting for sample @ https://www.delveinsight.com/sample-request/parkinsons-disease-related-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Parkinson's disease related Dementia Companies
• Acadia Pharmaceuticals
• Anavex life sciences
• Alkahest/Grifols
• And Many More

Parkinson's disease related Dementia Pipeline
• Nuplazid (pimavanserin)
• ANAVEX-273
• GRF6021
• And Many More

Know more about the pipeline therapies and recent developments, Click here: https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Key Insights
2. Executive Summary of Parkinson's Disease Related Dementia
3. Competitive Intelligence Analysis for Parkinson's Disease Related Dementia
4. Parkinson's Disease Related Dementia: Market Overview at a Glance
5. Parkinson's Disease Related Dementia: Disease Background and Overview
6. Patient Journey
7. Parkinson's Disease Related Dementia Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Parkinson's Disease Related Dementia Unmet Needs
10. Key Endpoints of Parkinson's Disease Related Dementia Treatment
11. Parkinson's Disease Related Dementia Marketed Products
12. Parkinson's Disease Related Dementia Emerging Therapies
13. Parkinson's Disease Related Dementia: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Parkinson's Disease Related Dementia
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

To download the TOC of the Report, Click here: https://www.delveinsight.com/sample-request/parkinsons-disease-related-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.